X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (744) 744
Publication (132) 132
Book Review (21) 21
Book / eBook (4) 4
Book Chapter (3) 3
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (682) 682
hiv infections - drug therapy (465) 465
index medicus (452) 452
anti-retroviral agents - therapeutic use (390) 390
female (311) 311
hiv (290) 290
male (267) 267
anti-retroviral agents - pharmacokinetics (245) 245
infectious diseases (224) 224
adult (197) 197
pharmacology & pharmacy (196) 196
pharmacokinetics (190) 190
anti-retroviral agents - administration & dosage (189) 189
antiviral agents (175) 175
antiretroviral therapy (166) 166
drug interactions (149) 149
immunology (146) 146
middle aged (139) 139
human immunodeficiency virus--hiv (137) 137
anti-retroviral agents - adverse effects (132) 132
anti-retroviral agents - pharmacology (126) 126
antiretroviral drugs (122) 122
drug therapy (122) 122
hiv infection (119) 119
highly active antiretroviral therapy (118) 118
animals (113) 113
therapy (113) 113
human-immunodeficiency-virus (107) 107
aids (105) 105
research (95) 95
hiv infections - complications (94) 94
treatment outcome (94) 94
virology (91) 91
viral load (90) 90
article (84) 84
health aspects (83) 83
protease inhibitors (80) 80
microbiology (78) 78
hiv infections - prevention & control (74) 74
aids/hiv (71) 71
drugs (70) 70
hiv-1 (70) 70
medicine, general & internal (70) 70
drug therapy, combination (69) 69
human immunodeficiency virus (69) 69
antiretroviral agents (67) 67
acquired immune deficiency syndrome--aids (65) 65
pregnancy (64) 64
young adult (64) 64
dosage and administration (63) 63
analysis (62) 62
hiv infections - virology (61) 61
adolescent (60) 60
hiv-1 - drug effects (60) 60
medicine (60) 60
infection (59) 59
tenofovir (59) 59
research article (58) 58
risk factors (58) 58
efavirenz (57) 57
prevention (57) 57
ritonavir (56) 56
cd4 lymphocyte count (55) 55
care and treatment (54) 54
child (53) 53
hiv-infected patients (53) 53
nevirapine (51) 51
virus diseases (50) 50
drug resistance, viral (49) 49
hiv infections - epidemiology (49) 49
active antiretroviral therapy (48) 48
hiv infections - metabolism (48) 48
children (47) 47
pharmacology (47) 47
antiretrovirals (46) 46
infected patients (45) 45
safety (45) 45
child, preschool (43) 43
infant (43) 43
reverse-transcriptase inhibitors (43) 43
antiretroviral therapy, highly active (42) 42
mortality (42) 42
zidovudine (42) 42
acquired immune deficiency syndrome (41) 41
adherence (41) 41
clinical trials as topic (41) 41
anti-retroviral agents - blood (40) 40
hiv patients (40) 40
acquired immunodeficiency syndrome - drug therapy (39) 39
usage (39) 39
aged (38) 38
infections (38) 38
lamivudine (38) 38
retrospective studies (38) 38
studies (38) 38
anti-retroviral agents - chemistry (37) 37
complications and side effects (37) 37
hiv infections - transmission (37) 37
hiv/aids (37) 37
pediatrics (37) 37
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (719) 719
Spanish (17) 17
French (9) 9
German (2) 2
Portuguese (2) 2
Japanese (1) 1
Russian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 03/2010, Volume 87, Issue 3, pp. 322 - 329
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 08/2013, Volume 63, Issue 4, pp. 449 - 455
Journal Article
Epilepsia, ISSN 0013-9580, 01/2013, Volume 54, Issue 1, pp. 11 - 27
Summary Several commonly prescribed antiepileptic drugs (AEDs)—including phenobarbital, phenytoin, and carbamazepine—stimulate the synthesis of a broad range... 
Enzyme‐inducing antiepileptic drug | Vascular disease | Drug metabolism | Pharmacokinetic interactions | Osteoporosis | Sexual dysfunction | DOSE-DEPENDENT INDUCTION | VASCULAR RISK-FACTORS | VITAMIN-D METABOLISM | NEWLY-DIAGNOSED EPILEPSY | QUALITY STANDARDS SUBCOMMITTEE | PREGNANE-X-RECEPTOR | CLINICAL NEUROLOGY | Enzyme-inducing antiepileptic drug | PATIENTS RECEIVING CARBAMAZEPINE | RECURRENT MALIGNANT GLIOMA | BRAIN-TUMOR CONSORTIUM | INCREASED BONE TURNOVER | Anticonvulsants - pharmacokinetics | Anti-Retroviral Agents - pharmacokinetics | Humans | Immunosuppressive Agents - pharmacokinetics | Anticonvulsants - therapeutic use | Male | Vascular Diseases - chemically induced | Pregnancy | Cytochromes - biosynthesis | Anticonvulsants - adverse effects | Drug Interactions | Enzyme Induction - drug effects | Epilepsy - drug therapy | Female | Antineoplastic Agents - pharmacokinetics | Contraceptives, Oral, Hormonal - pharmacokinetics | Antidepressive Agents - pharmacokinetics | Drugs | Antiviral agents | Enzymes | Corticosteroids | Comorbidity | Epilepsy | Anticoagulants (Medicine) | Blood circulation disorders | Phenobarbital | Physiological aspects | Hormones, Sex | Oral contraceptives | Sexual disorders | Statins | Phenytoin | Anticoagulants | Glucocorticoids | Antihypertensives | Toxicity | Withdrawal | Mortality | Antiepileptic agents | Immunosuppressive agents | Graft rejection | Sex hormones | Vascular diseases | Acquired immune deficiency syndrome | Analgesics | statins | Metabolic pathways | Cancer | Index Medicus
Journal Article
AIDS, ISSN 0269-9370, 09/2007, Volume 21, Issue 14, pp. 1899 - 1907
Objectives: To describe first dose and steady state antiretroviral drug exposure in the female genital tract. Design: Non-blinded, single center, open-label... 
Women | Genital tract | HIV | Prophylaxis | Sexual transmission | Pharmacokinetics | Antiretroviral therapy | genital tract | INFECTIOUS DISEASES | sexual transmission | antiretroviral therapy | EMTRICITABINE | IMMUNOLOGY | CEREBROSPINAL-FLUID | prophylaxis | BACTERIAL VAGINOSIS | PROTEASE INHIBITOR | TRICHOMONAS-VAGINALIS | HIV-INFECTION | THERAPY | VIROLOGY | LIQUID-CHROMATOGRAPHY | SIMIAN IMMUNODEFICIENCY VIRUS | pharmacokinetics | MACAQUES | women | Lamivudine - administration & dosage | Humans | Deoxycytidine - blood | Zidovudine - administration & dosage | Tenofovir | Deoxycytidine - pharmacokinetics | HIV Protease Inhibitors - pharmacokinetics | Atazanavir Sulfate | Genitalia, Female - metabolism | Emtricitabine | HIV Infections - blood | HIV Protease Inhibitors - blood | Adenine - analogs & derivatives | Pyridines - administration & dosage | Benzoxazines - administration & dosage | Administration, Oral | Anti-Retroviral Agents - pharmacokinetics | Deoxycytidine - administration & dosage | Lopinavir | HIV Protease Inhibitors - administration & dosage | Adenine - pharmacokinetics | Pyrimidinones - blood | Anti-Retroviral Agents - administration & dosage | Oligopeptides - administration & dosage | Pyrimidinones - administration & dosage | Zidovudine - blood | Deoxycytidine - analogs & derivatives | Reverse Transcriptase Inhibitors - blood | Zidovudine - pharmacokinetics | Pyridines - pharmacokinetics | Reverse Transcriptase Inhibitors - administration & dosage | Adenine - blood | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - pharmacokinetics | Adult | Benzoxazines - blood | Female | Organophosphonates - blood | Anti-Retroviral Agents - blood | Drug Therapy, Combination | Oligopeptides - blood | Oligopeptides - pharmacokinetics | Lamivudine - blood | Lamivudine - pharmacokinetics | Adenine - administration & dosage | Organophosphonates - pharmacokinetics | Organophosphonates - administration & dosage | Pyridines - blood | Pyrimidinones - pharmacokinetics | HIV Infections - drug therapy
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2017, Volume 56, Issue 1, pp. 25 - 40
Dolutegravir (DTG), elvitegravir (EVG) and raltegravir (RAL) are members of the latest class of antiretrovirals (ARVs) that have become available to treat... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | TWICE-DAILY RALTEGRAVIR | ONCE-DAILY DOLUTEGRAVIR | SERONEGATIVE SUBJECTS | TREATMENT-EXPERIENCED PATIENTS | NON-INFERIORITY TRIAL | CO-FORMULATED ELVITEGRAVIR | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | INFECTED PATIENTS | RANDOMIZED CONTROLLED-TRIAL | ANTIRETROVIRAL-NAIVE ADULTS | HIV Integrase Inhibitors - pharmacology | Coinfection | Area Under Curve | Humans | Raltegravir Potassium - therapeutic use | Half-Life | Metabolic Clearance Rate | HIV Integrase - metabolism | HIV Integrase Inhibitors - administration & dosage | Liver Failure - metabolism | Drug Interactions | Quinolones - pharmacokinetics | Quinolones - therapeutic use | Female | Heterocyclic Compounds, 3-Ring - pharmacokinetics | Anti-Retroviral Agents - therapeutic use | Raltegravir Potassium - pharmacokinetics | Anti-Retroviral Agents - pharmacokinetics | Anti-Retroviral Agents - pharmacology | HIV Integrase Inhibitors - pharmacokinetics | Renal Insufficiency - metabolism | Pregnancy | Cytochrome P-450 CYP3A - metabolism | Anti-Retroviral Agents - administration & dosage | Heterocyclic Compounds, 3-Ring - therapeutic use | HIV Integrase Inhibitors - therapeutic use | Protein Binding | HIV Infections - drug therapy | Drug Combinations | Antiviral agents | Usage | Care and treatment | Pharmacology | Research | Diagnosis | Pharmacokinetics | Comparative analysis | HIV infection | Cytochrome | Antiretroviral drugs | Enzymes | Infections | Glycoproteins | Metabolism | Patients | Studies | Proteins | Human immunodeficiency virus--HIV | Adults | Drug dosages | Volunteers
Journal Article
Journal Article
American Journal of Transplantation, ISSN 1600-6135, 12/2007, Volume 7, Issue 12, pp. 2816 - 2820
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 4/2017, Volume 56, Issue 4, pp. 355 - 369
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 01/2018, Volume 73, Issue 1, pp. 160 - 164
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 10/2004, Volume 37, Issue 2, pp. 1253 - 1262
Journal Article